Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
Journal of Biomolecular Screening
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (13)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Fogel, P.
Right arrow Articles by Guédini, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fogel, P.
Right arrow Articles by Guédini, D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

The Confirmation Rate of Primary Hits: A Predictive Model

Paul Fogel

Aventis Pharma, Romainville, France and 4 rue Le Goff, Paris, France

Pascal Collette

Aventis Pharma, Romainville, France and Galderma R&D, 635 route des Lucioles, Sophia Antipolis, Valbonne, France

Alain Dupront

Aventis Pharma, Romainville, France

Tina Garyantes

Aventis Pharmaceuticals, Inc., Bridgewater, NJ

Denis Guédini

Aventis Pharma, Romainville, France and Galderma R&D, 635 route des Lucioles, Sophia Antipolis, Valbonne, France

HTS data from primary screening are usually analyzed by setting a cutoff for activity, in order to minimize both false-negative and false-positive rates. An alternative approach, based on a calculated probability of being active, is presented here. Given the predicted confirmation rate derived from this probability, the number of primary positives selected for follow-up can be optimized to maximize the number of true positives without picking too many false positives. Typical cutoff-determining methods are more serendipitous in their nature and not easily optimized in an effort to optimize screening efforts. An additional advantage of calculating a probability of being active for each compound screened is that orthogonal mixtures can be deconvoluted without presetting a deconvolution threshold. An important consequence of using the probability of being active with orthogonal mixtures is that individual compound screening results can be recorded irrespective of whether the assays were performed on single compounds or on cocktails.

Journal of Biomolecular Screening, Vol. 7, No. 3, 175-190 (2002)
DOI: 10.1177/108705710200700303


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
J Biomol ScreenHome page
J.-h. Zhang, X. Wu, and M. A. Sills
Probing the Primary Screening Efficiency by Multiple Replicate Testing: A Quantitative Analysis of Hit Confirmation and False Screening Results of a Biochemical Assay
J Biomol Screen, October 1, 2005; 10(7): 695 - 704.
[Abstract] [PDF]


Home page
J Biomol ScreenHome page
J. R. Doyle, J. N. Burnell, D. S. Haines, L. E. Llewellyn, C. A. Motti, and D. M. Tapiolas
A Rapid Screening Method to Detect Specific Inhibitors of Pyruvate Orthophosphate Dikinase as Leads for C4 Plant-Selective Herbicides
J Biomol Screen, February 1, 2005; 10(1): 67 - 75.
[Abstract] [PDF]